Blocking inhibition to YAP by ActinomycinD enhances anti-tumor efficacy of Corosolic acid in treating liver cancer
Yanfeng Xu(Capital Medical University), Yongchun Yu(Weifang People's Hospital), Yinghui Zhao(Second Hospital of Shandong University), Guo‐Qing Zhu(Nanjing Medical University), Xiao Zhang(Tongji University), Yu Guan(Chinese Academy of Sciences), Jiayi Wang(Dalian University of Technology), Yan Chen(Tongji University), Fenyong Sun(Tongji University), Yanli Xu(Shanghai University of Traditional Chinese Medicine), Yuxin Chen(Nanjing Drum Tower Hospital), Qi Wu(Soochow University)
Cited by 32
Related Papers
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
|Cancer Communications|2021|657
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023
|癌症：英文版|2023|412
A guideline on the molecular ecosystem regulating ferroptosis
|Nature Cell Biology|2024|251
NLRP3 inflammasome activation contributes to VSMC phenotypic transformation and proliferation in hypertension
|Cell Death and Disease|2017|239
The essential role of YAP O-GlcNAcylation in high-glucose-stimulated liver tumorigenesis
|Nature Communications|2017|236